Pharma Mfg Business Raising Funds In Kolhapur

About Business

The pharmaceutical manufacturing business was incorporated in 2003; however, operations have remained dormant since 2023. The promoters are now seeking to restart and scale the business by bringing in a strategic investment partner.

The business is backed by an experienced pharmaceutical group with a legacy dating back to 1992, having built a strong reputation in contract manufacturing for multinational and leading Indian pharmaceutical companies. Over the years, the group has established expertise in manufacturing high-quality, affordable pharmaceutical formulations while maintaining stringent quality standards, regulatory compliance, and cost-efficient manufacturing practices.

The company operates as a one-stop pharmaceutical manufacturing solution, with capabilities to produce a broad range of formulations, including tablets, liquid orals, antacids, and alcohol-based external liquid preparations such as mouthwashes. It currently has approximately 35 formulations ready for commercialization, with several additional products under development for both domestic and export markets.

Clientele type

The group has an established track record of contract manufacturing for leading multinational and Indian pharmaceutical companies, serving reputed clients across the domestic and international pharmaceutical industry.

Premises

OWNED

Premise Size: 23000 Sq Ft built-up and 2 plants (8000 and 10000 sq. ft.)

Market Value (in INR): 35.00 Cr

The manufacturing infrastructure comprises two production facilities situated on land parcels of approximately 8,608 sq. ft. and 10,760 sq. ft., with a total constructed area of nearly 23,000 sq. ft. The facilities are equipped with modern manufacturing infrastructure, including self-leveling epoxy flooring in production areas, centralized boiler systems, industrial air compressors, dedicated air handling units (AHUs), purified water generation systems with RO and EDI technology, quality control laboratories, stability chambers, effluent treatment systems, and backup power infrastructure. The plants are designed to support large-scale pharmaceutical manufacturing while complying with WHO-GMP standards and regulatory requirements.

The facilities possess valid pharmaceutical manufacturing licenses issued by the relevant regulatory authorities, with approvals extending through 2027 and 2028, along with registration with the Sri Lankan Food and Drug Administration for export opportunities.

At full operational capacity, the manufacturing unit is capable of producing approximately 200,000 blister packs, 40,000 aluminium strips, and 50,000 bottles per shift, supported by an estimated workforce of around 85 employees across production, quality assurance, quality control, microbiology, engineering, maintenance, administration, finance, inventory, and support functions.

The promoters bring decades of pharmaceutical industry expertise. The founder possesses nearly 28 years of experience in pharmaceutical manufacturing, regulatory affairs, and quality systems, while the Group Technical Director has over 27 years of experience in core pharmaceutical manufacturing operations. The group's longstanding philosophy has been to continually reinvest profits into upgrading manufacturing facilities, technology, and quality systems.

Asking Price Includes

The promoter is looking to offer 49% stake in the business.

Asking Price

INR 17.00 Cr

Minimum ticket size

INR 15.00 Cr

Reason

The promoters are seeking a strategic partner by offering up to a 49% equity stake in the business. The investment will support the restart of operations, working capital requirements, commercialization of existing formulations, capacity utilization, and future business expansion.

Licenses

"FDA Product Licenses. License is in the Form 25, No.: PD/ 145 .valid upto 17/06/2028. License in the Form 28, No.: PD/ 91 valid upto 17/06/2028. Also we have Registered our Company with Srilanka FDA Authorities. " "FDA Product Licenses. License in the Fo

More Details

Backed by a pharmaceutical manufacturing legacy dating back to 1992.
Two fully developed manufacturing facilities with approximately 23,000 sq. ft. of constructed area.
WHO-GMP compliant infrastructure with modern utilities and quality control systems.
Approximately 35 market-ready formulations with additional products under development.
Valid pharmaceutical manufacturing licenses and export registration with the Sri Lankan regulatory authority.
Proven experience in contract manufacturing for globally recognized pharmaceutical companies.
Highly experienced promoters with over five decades of combined pharmaceutical manufacturing expertise.